Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lopez, Paul
NCT05654922: Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant	Recruiting	3	100	US	ARINA-1, Standard of care only	Renovion, Inc.	Pre-Bronchiolitis Obliterans Syndrome	01/25	06/25
TETON, NCT04708782: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis May 2024 - Aug 2024 : Topline data for IPF Jan 2023 - Mar 2023 : Enrollment completion of TETON trial for IPF	Recruiting	3	576	Canada, US	Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer	United Therapeutics	Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease	06/25	06/25
CLAD, NCT06476132: Belumosudil to Block Chronic Lung Allograft Dysfunction () in High Risk Lung Transplant Recipients	Recruiting	2	234	Canada, US	Belumosudil, Placebo for Belumosudil	National Institute of Allergy and Infectious Diseases (NIAID)	Lung Transplant	05/27	06/27
ALL IN LUNG, NCT06033196: Tocilizumab in Lung Transplantation	Recruiting	2	350	Canada, US	Tocilizumab, ACTEMRA, Placebo for Tocilizumab	National Institute of Allergy and Infectious Diseases (NIAID)	Lung Transplant	01/29	01/29